GOSS Kronos AI forecast
A 30-trading-day price forecast for Gossamer Bio Inc. (GOSS) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Gossamer Bio Inc. at $11.83 on 2026-12-08, +21.1% from the last close of $9.77 on 2026-10-27. Eight out of ten sampled paths end between $11.33 and $12.09, and 8 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of GOSS
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $9.46 | $9.17 | $10.28 |
| 2026-11-10 | $10.57 | $9.54 | $11.41 |
| 2026-11-17 | $10.87 | $9.81 | $12.11 |
| 2026-11-24 | $11.33 | $10.54 | $11.77 |
| 2026-12-01 | $11.71 | $11.13 | $12.17 |
| 2026-12-08 | $11.83 | $11.33 | $12.09 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for GOSS?
- Kronos AI's median forecast for GOSS is $11.83 in 30 trading days, +21.1% from the last close, with a 10–90% range of $11.33 to $12.09.
- Is the GOSS Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- LLY — Eli Lilly and Company
- JNJ — Johnson & Johnson
- ABBV — AbbVie Inc.
- MRK — Merck & Company Inc.
- NVS — Novartis AG
- AZN — AstraZeneca PLC